Company page

Xencor, Inc.

Xencor, Inc. is a public company traded on the American stock market under the ticker XNCR. With a market capitalization of approximately $937.15 million, Xencor focuses on developing innovative therapies for various diseases. The company is known for its work in the biotechnology sector, leveraging its proprietary technology to create new treatment options.